LLY logo

Eli Lilly and Company (LLY)

$1,427.28

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on LLY

Market cap

$1.34T

EPS

30.81

P/E ratio

39.5

Price to sales

13.93

Dividend yield

0.485%

Beta

0.398637

Price on LLY

Previous close

$1,437.29

Today's open

$1,446.55

Day's range

$1,427.28 - $1,460

52 week range

$850.51 - $1,460

Profile about LLY

CEO

Dave Ricks

Employees

50000

Headquarters

Indianapolis, IN

Exchange

New York Stock Exchange

Shares outstanding

940745031

Issue type

Common Stock

LLY industries and sectors

Healthcare

Pharmaceuticals

News on LLY

Mapping the Market: Eli Lilly shares ready to rally again

Shares in Eli Lilly rose more than 70% from their 2026 low to the record high they hit on Thursday, and more gains could be in store, technical analysis indicates.

news source

Reuters • 17 hours ago

news preview

HIMS Partners With Lilly to Offer FDA-Approved Weight-Loss Drugs

Hims & Hers unites with Lilly to offer FDA-approved weight-loss drugs, Zepbound and Foundayo, expanding patient access and strengthening its obesity care platform.

news source

Zacks Investment Research • 11 hours ago

news preview

4 Key Stocks to Watch Across Diabetes and Obesity This Awareness Day

LLY, NVO, VKTX and GPCR advance diabetes and obesity treatments, with promising drug candidates, expanding clinical studies and key pipeline milestones ahead.

news source

Zacks Investment Research • 13 hours ago

news preview

China approves Eli Lilly's weight loss pill orforglipron

Eli Lilly on Thursday became the ​first drugmaker to have a GLP-1 weight-loss pill approved in China, ‌giving it an edge over Danish rival Novo Nordisk (NOVOb.CO), opens new tab in the world's second-largest pharmaceutical market.

news source

Reuters • Nov 12, 2026

news preview

Nvidia CEO Jensen Huang Says AI's 'Most Profound Impact' Will Be in Life Sciences -- and Eli Lilly Is Already Building on It

AI could improve the drug discovery and development process. Eli Lilly has made an important move to benefit from this.

news source

The Motley Fool • Nov 12, 2026

news preview

More Good News for Eli Lilly Sends the Stock Even Higher

The medication also looks effective in reducing the severity of sleep apnea. Eli Lilly's share price rose on the news -- and there could be more in store.

news source

The Motley Fool • Nov 12, 2026

news preview

The world's most sophisticated drug companies are putting billions into vaccines — despite the political environment

Look at the promising data for Moderna and Merck's experimental cancer vaccine and the research suggesting the shingles vaccine can delay dementia.

news source

Market Watch • Nov 12, 2026

news preview

Lilly breaks ground in Pennsylvania's Lehigh Valley on a $3.5 billion site to make next-generation obesity medicines, the latest of 10 new U.S. sites since 2020

Facility will manufacture injectable medicines, including retatrutide Site will create 850 high-wage jobs and 2,000 construction jobs INDIANAPOLIS, Nov. 12, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today broke ground on a $3.5 billion manufacturing facility in Pennsylvania's Lehigh Valley. The site is one of 10 new U.S. manufacturing sites announced since 2020 and one of four among them dedicated to injectable medicines and devices.

news source

PRNewsWire • Nov 12, 2026

news preview

Can LLY's Expanding Obesity Pipeline Sustain Its GLP-1 Leadership?

Lilly's expanding obesity pipeline, led by oral Foundayo and next-generation candidates retatrutide and EloraTZP, could strengthen its GLP-1 market leadership.

news source

Zacks Investment Research • Nov 12, 2026

news preview

Nvidia CEO Out — 10 Stocks To Buy Before S&P 500 Hits 8,000

Nvidia (NVDA) is down over 30% from the highs with CEO Jensen Huang stepping down, yet Blanke Schein Wealth Management CIO Robert Schein says the stock is still a buy. He also names Broadcom (AVGO), Apple (AAPL), and Eli Lilly (LLY) among his top picks before the S&P 500 reaches 8,000.

news source

The Street • Nov 12, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Eli Lilly and Company

Open an M1 investment account to buy and sell Eli Lilly and Company commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in LLY on M1